The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
In a short-term perspective, the company has interesting fundamentals.
UnitedHealth Group accounts for 5.61 % of our USA Portfolio. A trade is currently open since 11/02/2015 with a purchase price of $ 130.26. Discover the other 19 stocks of the USA portfolio managed by the MarketScreener portfolio management team.
Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Historically, the company has been releasing figures that are above expectations.
Analysts covering this company mostly recommend stock overweighting or purchase.
The stock is in a well-established, long-term rising trend above the technical support level at 272.45 USD
Stock prices approach a strong long-term resistance in weekly data at USD 355.67.